These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1620357)
1. Report of the MDA Gene Therapy Conference, Tucson, Arizona, September 27-28, 1991. Rossiter BJ; Stirpe NS; Caskey CT Neurology; 1992 Jul; 42(7):1413-8. PubMed ID: 1620357 [TBL] [Abstract][Full Text] [Related]
2. Gene therapy for muscular dystrophies: current status and future prospects. Takeda S; Miyagoe-Suzuki Y BioDrugs; 2001; 15(10):635-44. PubMed ID: 11604045 [TBL] [Abstract][Full Text] [Related]
3. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Kumar-Singh R; Chamberlain JS Hum Mol Genet; 1996 Jul; 5(7):913-21. PubMed ID: 8817325 [TBL] [Abstract][Full Text] [Related]
4. Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route. Cho WK; Ebihara S; Nalbantoglu J; Gilbert R; Massie B; Holland P; Karpati G; Petrof BJ Hum Gene Ther; 2000 Mar; 11(5):701-14. PubMed ID: 10757350 [TBL] [Abstract][Full Text] [Related]
5. Cell and gene therapy in Duchenne muscular dystrophy. Morgan JE Hum Gene Ther; 1994 Feb; 5(2):165-73. PubMed ID: 7514447 [TBL] [Abstract][Full Text] [Related]
6. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice. Koo T; Popplewell L; Athanasopoulos T; Dickson G Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945 [TBL] [Abstract][Full Text] [Related]
8. The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases. Karpati G; Acsadi G Muscle Nerve; 1993 Nov; 16(11):1141-53. PubMed ID: 8413366 [TBL] [Abstract][Full Text] [Related]
9. The DMD gene promoter: a potential role in gene therapy. Ray PN; Klamut HJ; Worton RG Adv Exp Med Biol; 1990; 280():107-11; discussion 111-2. PubMed ID: 2248131 [TBL] [Abstract][Full Text] [Related]
10. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Phelps SF; Hauser MA; Cole NM; Rafael JA; Hinkle RT; Faulkner JA; Chamberlain JS Hum Mol Genet; 1995 Aug; 4(8):1251-8. PubMed ID: 7581361 [TBL] [Abstract][Full Text] [Related]
11. Cell transplantation and gene therapy in muscular dystrophy. Morgan JE; Partridge TA Bioessays; 1992 Sep; 14(9):641-5. PubMed ID: 1365921 [TBL] [Abstract][Full Text] [Related]
12. Myoblast transfer and gene therapy in muscular dystrophies. Pagel CN; Morgan JE Microsc Res Tech; 1995 Apr; 30(6):469-79. PubMed ID: 7599358 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery. Abmayr S; Gregorevic P; Allen JM; Chamberlain JS Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410 [TBL] [Abstract][Full Text] [Related]
14. [Advances in genome editing technologies for treating muscular dystrophy.]. Makita Y; Hozumi H; Hotta A Clin Calcium; 2017; 27(3):391-399. PubMed ID: 28232654 [TBL] [Abstract][Full Text] [Related]
15. The Dystrophin Complex: Structure, Function, and Implications for Therapy. Gao QQ; McNally EM Compr Physiol; 2015 Jul; 5(3):1223-39. PubMed ID: 26140716 [TBL] [Abstract][Full Text] [Related]
16. Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Dunckley MG; Wells DJ; Walsh FS; Dickson G Hum Mol Genet; 1993 Jun; 2(6):717-23. PubMed ID: 8353491 [TBL] [Abstract][Full Text] [Related]
17. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies. Cordier L; Gao GP; Hack AA; McNally EM; Wilson JM; Chirmule N; Sweeney HL Hum Gene Ther; 2001 Jan; 12(2):205-15. PubMed ID: 11177557 [TBL] [Abstract][Full Text] [Related]